Insmed (INSM) PT Raised to $237 at Barclays
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $126.68 --0%
Rating Summary:
32 Buy, 1 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 3 | New: 2
Rating Summary:
32 Buy, 1 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 3 | New: 2
Join SI Premium – FREE
Barclays analyst Eliana Merle raised the price target on Insmed (NASDAQ: INSM) to $237.00 (from $231.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Kepler Cheuvreux Downgrades Ipsos SA (IPS:FP) (IPSOF) to Hold
- National Beverage (FIZZ) PT Lowered to $32 at UBS
- Teva Pharma (TEVA) PT Raised to $48 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
